Canlyniadau Chwilio - Suazette Reid

Synthesis of pyridine derivatives as potential antagonists of chemokine receptor type 4 gan Mooring, Suazette Reid, Gaines, Theresa, Liang, Zhongxing, Shim, Hyunsuk

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Carbohydrate recognition by boronolectins, small molecules, and lectins gan Shan Jin, Yunfeng Cheng, Suazette Reid, Minyong Li, Binghe Wang

Cael y testun llawn

Benzenesulfonamides: A Unique Class of Chemokine Receptor Type 4 Inhibitors gan Mooring, Suazette Reid, Liu, Jin, Liang, Zhongxing, Ahn, Jeffrey, Hong, Samuel, Yoon, Younghyoun, Snyder, James P., Shim, Hyunsuk

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Symmetrical bis-tertiary amines as novel CXCR4 inhibitors gan Bai, Renren, Liang, Zhongxing, Yoon, Younghyoun, Liu, Shuangping, Gaines, Theresa, Oum, Yoonhyeun, Shi, Qi, Mooring, Suazette Reid, Shim, Hyunsuk

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Design and Synthesis of Novel Small-molecule Inhibitors of the Hypoxia Inducible Factor Pathway gan Mooring, Suazette Reid, Jin, Hui, Devi, Narra S., Jabbar, Adnan A., Kaluz, Stefan, Liu, Yuan, Van Meir, Erwin G., Wang, Binghe

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Sulfonamides as a New Scaffold for Hypoxia Inducible Factor Pathway Inhibitors gan Tan, Chalet, de Noronha, Rita, Devi, Narra S., Jabbar, Adnan A., Kaluz, Stefan, Liu, Yuan, Mooring, Suazette Reid, Nicolaou, K.C., Wang, Binghe, Van Meir, Erwin G.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor gan Shi, Qi, Yin, Shaoman, Kaluz, Stefan, Ni, Nanting, Devi, Narra Sarojini, Mun, Jiyoung, Wang, Danzhu, Damera, Krishna, Chen, Weixuan, Burroughs, Sarah, Mooring, Suazette Reid, Goodman, Mark M., Van Meir, Erwin G., Wang, Binghe, Snyder, James P.

Cael y testun llawn Cael y testun llawn Cael y testun llawn